132 related articles for article (PubMed ID: 20206886)
1. Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI.
Roubille F; Samri A; Cornillet L; Sportouch-Dukhan C; Davy JM; Raczka F; Gervasoni R; Pasquie JL; Cung TT; Piot C; Macia JC; Cransac F; Leclercq F
Eur J Intern Med; 2010 Apr; 21(2):131-6. PubMed ID: 20206886
[TBL] [Abstract][Full Text] [Related]
2. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
[TBL] [Abstract][Full Text] [Related]
3. The long-term prognostic value of multiple biomarkers following a myocardial infarction.
Brügger-Andersen T; Aarsetøy H; Grundt H; Staines H; Nilsen DW
Thromb Res; 2008; 123(1):60-6. PubMed ID: 18387656
[TBL] [Abstract][Full Text] [Related]
4. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
[TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
6. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting.
Ketch TR; Turner SJ; Sacrinty MT; Lingle KC; Applegate RJ; Kutcher MA; Sane DC
Am Heart J; 2008 Aug; 156(2):234-40. PubMed ID: 18657651
[TBL] [Abstract][Full Text] [Related]
7. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
[TBL] [Abstract][Full Text] [Related]
8. Multimarker strategy for risk prediction in patients presenting with acute dyspnea to the emergency department.
Christ M; Laule K; Klima T; Hochholzer W; Breidthardt T; Perruchoud AP; Mueller C
Int J Cardiol; 2008 May; 126(1):73-8. PubMed ID: 17481748
[TBL] [Abstract][Full Text] [Related]
9. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G
Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score.
Kuklinska AM; Sobkowicz B; Mroczko B; Sawicki R; Musial WJ; Knapp M; Dobrzycki S; Szmitkowski M
Clin Chim Acta; 2007 Jul; 382(1-2):106-11. PubMed ID: 17482153
[TBL] [Abstract][Full Text] [Related]
11. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
Foussas SG; Zairis MN; Lyras AG; Patsourakos NG; Tsirimpis VG; Katsaros K; Beldekos DJ; Handanis SM; Mytas DZ; Karidis KS; Tselioti PG; Prekates AA; Ambrose JA
Am J Cardiol; 2005 Aug; 96(4):533-7. PubMed ID: 16098307
[TBL] [Abstract][Full Text] [Related]
12. The long pentraxin 3 (PTX3): a novel prognostic inflammatory marker for mortality in acute chest pain.
Brügger-Andersen T; Pönitz V; Kontny F; Staines H; Grundt H; Sagara M; Nilsen DW
Thromb Haemost; 2009 Sep; 102(3):555-63. PubMed ID: 19718477
[TBL] [Abstract][Full Text] [Related]
13. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
14. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes.
Möckel M; Danne O; Müller R; Vollert JO; Müller C; Lueders C; Störk T; Frei U; Koenig W; Dietz R; Jaffe AS
Clin Chim Acta; 2008 Jul; 393(2):103-9. PubMed ID: 18423399
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory markers and cardiac function in acute coronary syndrome: difference in ST-segment elevation myocardial infarction (STEMI) and in non-STEMI models.
Di Stefano R; Di Bello V; Barsotti MC; Grigoratos C; Armani C; Dell'Omodarme M; Carpi A; Balbarini A
Biomed Pharmacother; 2009 Dec; 63(10):773-80. PubMed ID: 19906505
[TBL] [Abstract][Full Text] [Related]
16. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
Richards AM; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton C; Turner J; Crozier IG; Yandle TG
Circulation; 2003 Jun; 107(22):2786-92. PubMed ID: 12771003
[TBL] [Abstract][Full Text] [Related]
17. Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes.
Bodí V; Sanchis J; Llàcer A; Fácila L; Núñez J; Pellicer M; Bertomeu V; Ruiz V; Chorro FJ
Am Heart J; 2005 Feb; 149(2):268-74. PubMed ID: 15846264
[TBL] [Abstract][Full Text] [Related]
18. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
Raposeiras Roubín S; Barreiro Pardal C; Roubín-Camiña F; Ocaranza Sanchez R; Alvarez Castro E; Paradela Dobarro B; García-Acuña JM; Aguiar Souto P; Jacquet Hervet M; Castromán MJ; Arufe I; Outes B; Reino-Maceiras MV; Abu Assi E; González-Juanatey JR
Rev Port Cardiol; 2013 Feb; 32(2):117-22. PubMed ID: 23337430
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.
McCann CJ; Glover BM; Menown IB; Moore MJ; McEneny J; Owens CG; Smith B; Sharpe PC; Young IS; Adgey JA
Am J Cardiol; 2009 Jan; 103(1):22-8. PubMed ID: 19101224
[TBL] [Abstract][Full Text] [Related]
20. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
